 |
|
Management of a Pregnant Patient with Graves' Disease Complicated by Propylthiouracil induced Agranulocytosis
Yoon-Young Cho, Ho Sang Shon, Hyun Dae Yoon
Korean J Intern Med. 2005;20(4):335-338. Published online 2005 Dec 31 DOI: https://doi.org/10.3904/kjim.2005.20.4.335
|
|
Citations to this article as recorded by
 Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
Farrukh Munir, Hafiza Wajeeha Javaid, Muhammad Burhan Majeed Rana, Fatima Shaukat
Cureus.2022;[Epub] CrossRef Safety of antithyroid drugs in pregnancy: update and therapy implications
Thanuya Francis, Niroshan Francis, John H. Lazarus, Onyebuchi E. Okosieme
Expert Opinion on Drug Safety.2020; 19(5): 565. CrossRef A Comprehensive Metabolic Modeling of Thyroid Pathway in Relation to Thyroid Pathophysiology and Therapeutics
Manish Kumar Gupta, Dev Bukhsh Singh, Rohit Shukla, Krishna Misra
OMICS: A Journal of Integrative Biology.2013; 17(11): 584. CrossRef Antioxidant and Protective Effects ofBupleurum falcatumon the L-Thyroxine-Induced Hyperthyroidism in Rats
Seong-Mo Kim, Sang-Chan Kim, In-Kwon Chung, Woo-Hyun Cheon, Sae-Kwang Ku
Evidence-Based Complementary and Alternative Medicine.2012; 2012: 1. CrossRef Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients
Hemamalini Malligarjunan, Pushpa Gnanaraj, Swapna Subramanian, Tamilselvi Elango, Haripriya Dayalan
Clinical Biochemistry.2011; 44(14-15): 1209. CrossRef Propylthiouracil-Induced Agranulocytosis in the Third Trimester of Pregnancy
Ally Murji, Mara L. Sobel, Denice S. Feig, Mathew Sermer
Obstetrics & Gynecology.2010; 116(2): 485. CrossRef
|